Biocon Q4 makes 78 percent profit

Indian biotechnology firm Biocon reported a 78 per cent jump in consolidated net profit for its fourth quarter, said Chairman and Managing Director Kiran Mazumdar-Shaw on Thursday. During the quarter, Biocon reported exceptional gain of rupees 105.06 crore (USD 16542277) on account of share sale in Syngene.